Opportunity Information: Apply for PAS 10 098
Apply for PAS 10 098
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Technology Based Adherence Interventions for Substance Abusing Populations with HIV (R34)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Feb 16, 2010 and posted on Jan 27, 2010.
- Applicants must submit their applications by May 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments Special district governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Small businesses For profit organizations other than small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Technology Based Adherence Interventions for Substance Abusing Populations with HIV (R34)" (Funding Opportunity Number PAS 10 098) is a National Institutes of Health program led by the National Institute on Drug Abuse (NIDA) focused on improving HIV treatment adherence among people who use or abuse substances. The central idea is to support early stage research that designs, refines, and tests technology driven approaches that help individuals take HIV medications consistently and stay connected to care, especially in the real world situations where adherence often breaks down. Rather than relying only on clinic based reminders or infrequent check ins, the program emphasizes interventions that can operate in naturally occurring timeframes and contexts, meaning tools that work during day to day life when cravings, unstable housing, mental health symptoms, or chaotic schedules can interfere with treatment.
A key feature of this FOA is its emphasis on technology as the vehicle for adherence support. NIDA highlights a broad menu of possible tools, including mobile enabling technologies, Ecological Momentary Assessment (EMA), enhanced Medication Event Monitoring Systems, computer software, portable digital devices, and cell phones or digital assistant devices. In practice, this could include systems that monitor adherence patterns, deliver tailored prompts, capture real time self reports about substance use triggers, or provide immediate links to support when someone is at risk of missing doses. The underlying goal is to develop and pilot interventions that do more than educate; they are meant to respond to an individuals situation as it unfolds, using technology to deliver timely, actionable help.
The FOA is structured around the R34 mechanism, which is typically used for developmental work such as intervention development, feasibility studies, and pilot testing. This means the expected projects are not necessarily large, definitive efficacy trials; instead, they are meant to establish whether a technology based adherence approach is workable, acceptable to the target population, and promising enough to justify a larger follow on study. NIDA notes that this announcement runs in parallel with a companion FOA of identical scientific scope that uses the R01 mechanism (PAS 10 097), which is generally more appropriate for larger, more fully powered research projects. Applicants are therefore being guided to choose a mechanism that matches the maturity of their intervention and evidence base.
Multidisciplinary collaboration is strongly encouraged. NIDA specifically calls for teams that bring together social scientists, medical researchers (including physicians and nurses), and technology experts. The rationale is that improving adherence in substance using populations involves more than programming an app or sending reminders; it requires understanding behavior change, addiction dynamics, clinical HIV care, privacy and usability constraints, and how to build reliable tools that can function outside controlled research settings. The FOA also explicitly welcomes work on developing and refining mobile instrumentation, e health technologies, and software as interventions themselves or as core components of broader interventions that improve adherence and real time access to care.
Funding for the program was planned at up to 1.5 million in total costs in FY 2010 and up to 1.5 million in FY 2011, with an anticipated total of 6 to 9 new projects supported across this R34 FOA and the companion R01 FOA. The listed award ceiling is 250,000, aligning with the smaller, pilot oriented nature of the R34 mechanism. There is no cost sharing or matching requirement, which reduces barriers for applicants who may not have substantial non federal resources.
Eligibility is broad and includes many organization types that could realistically conduct or partner on HIV and substance use research. Eligible applicants include public and state controlled institutions of higher education, private institutions of higher education, nonprofits (including 501(c)(3) organizations and certain nonprofits without 501(c)(3) status), state and local governments (including counties, cities, townships, special districts), independent school districts, public housing authorities, Native American tribal governments and tribal organizations, small businesses, and other for profit organizations. The FOA also lists additional eligible applicants such as faith based and community based organizations, historically black colleges and universities (HBCUs), Hispanic serving institutions, Alaska Native and Native Hawaiian serving institutions, tribally controlled colleges and universities (TCCUs), regional organizations, U.S. territories or possessions, federal agencies, and non U.S. entities (foreign organizations). That wide eligibility reflects the reality that successful adherence interventions often require community embedded recruitment and implementation settings, not just academic medical centers.
Administratively, the opportunity falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs) and is categorized under education and health within discretionary grant funding. It was posted January 27, 2010, with key dates including an original closing date of September 7, 2012, a listed current closing date of May 7, 2011, and an archive date of June 7, 2011. The administering agency is NIH, and the full announcement was made available through the NIH grants guide (link provided in the source). For access or technical issues, the contact route is through the NIH Office of Extramural Research (OER) webmaster.
In short, this FOA is aimed at building the next generation of practical, real time, technology enabled adherence supports for HIV positive people who use substances, with a strong emphasis on feasibility and pilot testing, collaboration across disciplines, and interventions that function in the everyday conditions where adherence challenges actually occur.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled "Technology Based Adherence Interventions for Substance Abusing Populations with HIV (R34)."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is PAS 10 098.
Which federal agency and institute lead this program?
The administering agency is the National Institutes of Health (NIH), and the program is led by the National Institute on Drug Abuse (NIDA).
What problem is this FOA trying to address?
This FOA focuses on improving HIV treatment adherence among people who use or abuse substances, particularly where day-to-day life challenges (for example cravings, unstable housing, mental health symptoms, or chaotic schedules) can disrupt taking HIV medications consistently and staying connected to care.
What types of projects does the R34 mechanism support under this FOA?
The R34 mechanism is intended for early stage, developmental work such as intervention development, refinement, feasibility studies, and pilot testing. Projects are not necessarily expected to be large, definitive efficacy trials; the goal is to determine whether an approach is workable, acceptable, and promising enough for a larger follow-on study.
What is the central idea behind the interventions encouraged by this FOA?
The FOA emphasizes technology-driven adherence support that can function in naturally occurring timeframes and contexts, meaning it is designed to work during everyday life when adherence typically breaks down, rather than relying only on clinic-based reminders or infrequent check-ins.
What kinds of technologies are mentioned as examples?
NIDA lists a broad range of tools, including mobile enabling technologies, Ecological Momentary Assessment (EMA), enhanced Medication Event Monitoring Systems, computer software, portable digital devices, and cell phones or digital assistant devices.
What are examples of what a technology-based adherence intervention might do?
Based on the FOA description, interventions could monitor adherence patterns, deliver tailored prompts, capture real-time self-reports related to substance use triggers, or provide immediate links to support when someone is at risk of missing doses.
Is the FOA focused on education-only approaches?
No. The stated goal is to develop and pilot interventions that do more than educate by responding to an individual's situation as it unfolds and delivering timely, actionable help using technology.
Does this FOA encourage work on e-health tools and software development?
Yes. The FOA explicitly welcomes developing and refining mobile instrumentation, e-health technologies, and software as interventions themselves or as core components of broader interventions that improve adherence and real-time access to care.
Is multidisciplinary collaboration expected or encouraged?
Multidisciplinary collaboration is strongly encouraged, including teams that bring together social scientists, medical researchers (including physicians and nurses), and technology experts.
Why does NIDA emphasize multidisciplinary teams for this topic?
The FOA frames adherence in substance-using populations as a complex challenge that involves behavior change, addiction dynamics, clinical HIV care, privacy and usability constraints, and building reliable tools that operate outside controlled research settings.
Is there a companion funding opportunity using a different mechanism?
Yes. This announcement runs in parallel with a companion FOA of identical scientific scope using the R01 mechanism (PAS 10 097), which is generally aligned with larger, more fully powered research projects.
How should an applicant choose between the R34 and the companion R01?
Applicants are guided to select a mechanism that matches the maturity of the intervention and the existing evidence base, with R34 aligned to developmental and pilot work and R01 aligned to larger projects.
What is the maximum award amount listed for this FOA?
The listed award ceiling is 250,000, consistent with the smaller, pilot-oriented nature of the R34 mechanism.
How much total funding was planned for this program?
Planned funding was up to 1.5 million in total costs in FY 2010 and up to 1.5 million in FY 2011.
About how many awards were anticipated?
The FOA anticipated a combined total of 6 to 9 new projects supported across this R34 FOA and the companion R01 FOA.
Is cost sharing or matching required?
No. The FOA states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is broad and includes: public and state controlled institutions of higher education; private institutions of higher education; nonprofits (including 501(c)(3) organizations and certain nonprofits without 501(c)(3) status); state and local governments (including counties, cities, townships, and special districts); independent school districts; public housing authorities; Native American tribal governments and tribal organizations; small businesses; and other for-profit organizations.
Are community-based, faith-based, and minority-serving organizations eligible?
Yes. The FOA lists additional eligible applicants such as faith-based and community-based organizations, historically black colleges and universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities (TCCUs), and regional organizations.
Are U.S. territories, federal agencies, or non-U.S. entities eligible?
Yes. The FOA includes U.S. territories or possessions, federal agencies, and non-U.S. entities (foreign organizations) among eligible applicants.
What is the CFDA number associated with this opportunity?
The CFDA number is 93.279 (Drug Abuse and Addiction Research Programs).
How is this opportunity categorized?
It is categorized under discretionary grant funding and falls within education and health.
When was the opportunity posted?
The posting date listed is January 27, 2010.
What are the key dates (closing and archive dates) shown in the listing?
The listing includes an original closing date of September 7, 2012, a listed current closing date of May 7, 2011, and an archive date of June 7, 2011.
Where was the full announcement made available?
The full announcement was made available through the NIH grants guide (the source notes that a link was provided).
Who should be contacted for access or technical issues?
For access or technical issues, the contact route is through the NIH Office of Extramural Research (OER) webmaster.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Recovery Act BLMCO Survey Upper Crossing Guard Station Saguache
Previous opportunity: DoD Ovarian Cancer Translational Pilot Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAS 10 098
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAS 10 098) also looked into and applied for these:
| Funding Opportunity |
|---|
| Chronic Co Morbid Conditions in HIV U.S. Adults on Highly Effective Anti Retroviral Therapy (R01) Apply for RFA NR 10 001 Funding Number: RFA NR 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Chronic Co Morbid Conditions in HIV U.S. Adults on Highly Effective Anti Retroviral Therapy (R21) Apply for RFA NR 10 002 Funding Number: RFA NR 10 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31) Apply for PA 10 108 Funding Number: PA 10 108 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Comprehensive Partnerships to Reduce Cancer Health Disparities (Limited Competition U54) Apply for RFA CA 10 503 Funding Number: RFA CA 10 503 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Advancing Palliative Care Research for Children Facing Life Limiting Conditions (R21) Apply for RFA NR 10 007 Funding Number: RFA NR 10 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Advancing Palliative Care Research for Children Facing Life Limiting Conditions (R01) Apply for RFA NR 10 006 Funding Number: RFA NR 10 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Common Pathogenetic Mechanisms of Lung Cancer and COPD (R01) Apply for RFA HL 11 002 Funding Number: RFA HL 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Collaborative Clinical Trials in Drug Abuse (Collaborative R01) Apply for PAR 10 099 Funding Number: PAR 10 099 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Strategic Partnering to Evaluate Cancer Signatures SPECS II (U01) Apply for PAR 10 126 Funding Number: PAR 10 126 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Epigenetic Factors Associated with Symptoms and Complications of Chronic Disorders (Competitive Revision R01) Apply for RFA NR 10 005 Funding Number: RFA NR 10 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Epigenetic Factors Associated with Symptoms and Complications of Chronic Disorders (R01) Apply for RFA NR 10 004 Funding Number: RFA NR 10 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R03) Apply for PA 10 131 Funding Number: PA 10 131 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R01) Apply for PA 10 129 Funding Number: PA 10 129 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R21) Apply for PA 10 130 Funding Number: PA 10 130 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Medical Education Partnership Initiative (MEPI) (R24) Apply for RFA TW 10 008 Funding Number: RFA TW 10 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Research Education Program for Laboratory Animal Medicine Veterinarians (R25) Apply for RFA RR 10 002 Funding Number: RFA RR 10 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $224,000 |
| Next Generation Genetic Association Studies (U01) Apply for RFA HL 11 006 Funding Number: RFA HL 11 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21) Apply for PA 10 088 Funding Number: PA 10 088 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Development of Animal Models and Related Biological Materials For Research (R21) Apply for PA 10 138 Funding Number: PA 10 138 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Diet Composition and Energy Balance (R01) Apply for PA 10 152 Funding Number: PA 10 152 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAS 10 098", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
